Literature DB >> 1557666

Women and AIDS in developing countries.

M de Bruyn.   

Abstract

It is estimated that 8-10 million people worldwide are infected with HIV, the virus causing AIDS; a large proportion live in developing countries. A review of the recent literature reveals that the impact of HIV/AIDS is particularly great on women in developing countries for four reasons. (1) Stereotypes related to HIV/AIDS have meant that women are either blamed for their spread or not recognized as potential patients with the disease. The consequences can be: delayed diagnosis and treatment, stigmatization, loss of income and violations of human rights. (2) Women are at increased risk of exposure to HIV infection for reasons related indirectly and directly to their gender. (3) The psychological and social burdens are greater for women than men in a similar situation. These include: problems related to pregnancy and motherhood; rejection as marital partners, loss of security and income (if they or their partners are seropositive); and greater demands to cope with the effects of the epidemic, both as lay persons and professionals. (4) Women's frequently low socioeconomic status and lack of power make it difficult for them to undertake prevention measures. Prevention programs targeting sex workers have begun and need to be continued. However, more programs are needed for women in general, including older women, men, traditional health practitioners and opinion leaders, incorporating seropositive women wherever possible. In addition, HIV/AIDS-related research regarding women must be increased as well as their access to adequate health services and income-earning opportunities.

Entities:  

Mesh:

Year:  1992        PMID: 1557666     DOI: 10.1016/0277-9536(92)90267-t

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  14 in total

1.  Community-level HIV intervention work for women means restructuring society and culture.

Authors:  E L Gollub; D Metzger
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

2.  Low prevalences of HIV infection and sexually transmitted disease among female commercial sex workers in Mexico City.

Authors:  F Uribe-Salas; M Hernández-Avila; C J Conde-González; L Juárez-Figueroa; B Allen; R Anaya-Ocampo; C Del Río-Chiriboga; P Uribe-Zúñiga; B de Zalduondo
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

Review 3.  Understanding the scourge of HIV/AIDS in sub-Saharan Africa.

Authors:  Joseph Inungu; Sarah Karl
Journal:  MedGenMed       Date:  2006-11-09

4.  HIV infection and pregnancy status among adults attending voluntary counseling and testing in 2 developing countries.

Authors:  Andrew D Forsyth; Thomas J Coates; Olga A Grinstead; Gloria Sangiwa; Donald Balmer; Munkolenkole C Kamenga; Steven E Gregorich
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

5.  Tuberculosis in England and Wales. Define high risk behaviours, not high risk groups.

Authors:  I Smith
Journal:  BMJ       Date:  1995-07-15

Review 6.  Clinical aspects of HIV infection in women.

Authors:  G O Coodley; M K Coodley; A F Thompson
Journal:  J Gen Intern Med       Date:  1995-02       Impact factor: 5.128

7.  Factors associated with HIV infection are not the same for all women.

Authors:  E V Boisson; L C Rodrigues
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

8.  Men's multiple sexual partnerships in 15 Sub-Saharan African countries: sociodemographic patterns and implications.

Authors:  Jeffrey B Bingenheimer
Journal:  Stud Fam Plann       Date:  2010-03

9.  Effects of incarceration on HIV-infected individuals.

Authors:  M M Griffin; J G Ryan; V S Briscoe; K M Shadle
Journal:  J Natl Med Assoc       Date:  1996-10       Impact factor: 1.798

10.  'It's really a hard life': love, gender and HIV risk among male-to-female transgender persons.

Authors:  Rita M Melendez; Rogério Pinto
Journal:  Cult Health Sex       Date:  2007 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.